Mucosal Application of a Low-Energy Electron Inactivated Respiratory Syncytial Virus Vaccine Shows Protective Efficacy in an Animal Model

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections in the elderly and in children, associated with pediatric hospitalizations. Recently, first vaccines have been approved for people over 60 years of age applied by intramuscular injection. However, a vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Eberlein, Valentina, Ahrends, Mareike, Bayer, Lea, Finkensieper, Julia, Besecke, Joana Kira, Mansuroglu, Yaser, Standfest, Bastian, Lange, Franziska, Schopf, Simone, Thoma, Martin, Dressman, Jennifer, Hesse, Christina, Ulbert, Sebastian, Grunwald, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535182/
https://www.ncbi.nlm.nih.gov/pubmed/37766253
http://dx.doi.org/10.3390/v15091846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535182/
https://www.ncbi.nlm.nih.gov/pubmed/37766253
http://dx.doi.org/10.3390/v15091846

Ejemplares similares